Skip to Main Content

Author Details

Huandong Sun
2014
14
11
PMIDPaper TitleJournal TitlePublished Year
36050658Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.BMC Cancer2022
32878980A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.Sci Transl Med2020
32183953Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.Cancer Cell2020
31610796Global impact of somatic structural variation on the DNA methylome of human cancers.Genome Biol2019
31588020Pan-Cancer Landscape and Analysis of ERBB2 Mutations Identifies Poziotinib as a Clinically Active Inhibitor and Enhancer of T-DM1 Activity.Cancer Cell2019
29686424Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.Nat Med2018
29996110A Pan-Cancer Compendium of Genes Deregulated by Somatic Genomic Rearrangement across More Than 1,400 Cases.Cell Rep2018
30228210Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in <i>EGFR</i>-Mutant NSCLC.Clin Cancer Res2018
29743287PTPN12/PTP-PEST Regulates Phosphorylation-Dependent Ubiquitination and Stability of Focal Adhesion Substrates in Invasive Glioblastoma Cells.Cancer Res2018
29118262Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.Sci Transl Med2017
28528867A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.Cancer Cell2017
26526986Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis.Leukemia2016
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
25301631Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.Science2014
  • 1 - 14 of 14

Recommended Authors

Collaborators

University of Texas MD Anderson Cancer Center
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 6
The University of MD Anderson Cancer Center
Co-authored papers 5
The University of MD Anderson Cancer Center
Co-authored papers 5
The University of MD Anderson Cancer Center
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Harvard Medical School
Co-authored papers 4
University of Chicago, USA University of Chicago Comprehensive Cancer Center
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 4
Ulsan National Institute of Science and Technology (UNIST)
Co-authored papers 4
University of Kentucky College of Medicine
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 4
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
The University of MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Injury Prevention Research Center, University of North Carolina
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
University of Texas MD Anderson Cancer Center
Co-authored papers 2
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 2